Saltar al contenido
Merck

RAD50 regulates mitotic progression independent of DNA repair functions.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2020-01-08)
Lea Völkening, Anna Vatselia, Girmay Asgedom, Holger Bastians, Martin Lavin, Detlev Schindler, Axel Schambach, Kristine Bousset, Thilo Dörk
RESUMEN

The Mre11A/RAD50/NBN complex (MRN) is an essential regulator of the cellular damage response after DNA double-strand breaks (DSBs). More recent work has indicated that MRN may also impact on the duration of mitosis. We show here that RAD50-deficient fibroblasts exhibit a marked delay in mitotic progression that can be rescued by lentiviral transduction of RAD50. The delay was observed throughout all mitotic phases in live cell imaging using GFP-labeled H2B as a fluorescent marker. In complementation assays with RAD50 phosphorylation mutants, modifications at Ser635 had little effect on mitotic progression. By contrast with RAD50, fibroblast strains deficient in ATM or NBN did not show a significant slowing of mitotic progression. Ataxia-telangiectasia-like disorder (ATLD) fibroblasts with nuclease-deficient MRE11A (p.W210C) tended to show slower mitosis, though by far not as significant as RAD50-deficient cells. Inhibitor studies indicated that ATM kinase activity might not grossly impact on mitotic progression, while treatment with MRE11A inhibitor PFM39 modestly prolonged mitosis. Inhibition of ATR kinase significantly prolonged mitosis but this effect was mostly independent of RAD50 status. Taken together, our data unravel a mitotic role of RAD50 that can be separated from its known functions in DNA repair.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
PFM01, ≥98% (HPLC)
Sigma-Aldrich
PFM39, ≥98% (HPLC)